NODE 301: Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for th - Adventist HealthCare

Clinical Trial Details

NODE 301

NODE 301: Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Paroxysmal supraventricular tachycardia (PSVT)
Study Type: Interventional
Phase: Phase III
Study Start Date: 06/18/2018
Study Completion Date: 07/2020

This trial aims to evaluate the efficacy and safety of etripamil NS 70 mg self-administered by patients who experience an episode of PSVT in an outpatient setting.

NCT Number
NCT03464019
Principal Investigator(s)
Sean Beinart, MD
Sponsor(s)
Milestone Pharmaceuticals
Participant Eligibility
  • Age: 18 years and older
  • Gender: Male, Female

Location

  • Adventist HealthCare Shady Grove Medical Center
    9901 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6000
    Alternate: 240-826-6405

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.